123I isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer:: Comparison with post 131I therapy whole body scanning

被引:34
作者
Alzahrani, AS
Bakheet, S
Al Mandil, M
Al-Hajjaj, A
Almahfouz, A
Al Haj, A
机构
[1] King Faisal Specialist Hosp & Res Ctr, Dept Med MBC46, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Radiol, Riyadh 11211, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Surg, Riyadh 11211, Saudi Arabia
[4] King Faisal Specialist Hosp & Res Ctr, Dept Biomed Phys, Riyadh 11211, Saudi Arabia
关键词
D O I
10.1210/jc.86.11.5294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Radioactive iodine (I-131) plays a major role in the diagnosis and management of differentiated thyroid cancer (DTC); however, data on the use of the I-123 isotope in DTC are limited. We compared 238 diagnostic whole body scans performed 24 h after oral ingestion of 185-555 MBq I-123 with their corresponding I-131 posttherapy whole body scans obtained 4-5 d after I-131 therapy. We studied scans in 3 clinical situations: with the first I-131 therapy, with the second I-131 therapy, and in cases of elevated Tg and negative diagnostic scan. One hundred and seventy-seven pairs were obtained with the first I-131 therapy and showed complete concordance between pretreatment and posttreatment scans in 166 pairs (concordance rate, 93.8%). Six other posttreatment scans showed more foci in the thyroid bed than the pretreatment scans, but no evidence of uptake in new areas. Only 5 posttreatment scans showed foci in new locations: 3 in cervical lymph nodes (CLN), 1 in the lung, and I new bone metastasis in a patient with known skeletal metastases. With the second I-131 therapy, 34 pairs were obtained and showed complete concordance in 28 pairs (concordance rate, 82.4%). Five discordant pairs showed additional foci in areas that were already positive on pretreatment scans. Only 1 posttreatment scan showed a new bone metastasis in a different site from the bone metastases that were seen on its corresponding pretreatment scan. Of 27 pairs of scans in patients with elevated Tg and negative pretreatment scans, 15 posttreatment scans remained negative, 6 posttreatment scans showed an uptake in the thyroid bed, and 3 other posttreatment scans showed lung uptake in patients whose computed tomography scans of the chest showed only bronchiectasis (in 2 patients) and lung scarring (in the third patient) without evidence of lung metastases. Three posttreatment scans showed definite uptake (in thyroid bed, thyroid bed and lung, and CLN) compared with their corresponding pretreatment scans, which were initially reported negative but were retrospectively thought to have had faint uptake. In 56 pretreatment scans, the I-123 diagnostic activity was 185 MBq, and the results showed complete concordance in 54 pairs. Two posttreatment scans showed additional uptake: 1 in the bone and I in CLN. These data suggest that pretreatment scanning using I-123 is highly comparable to I-131 posttreatment scanning and that I-123 is an excellent diagnostic agent in DTC.
引用
收藏
页码:5294 / 5300
页数:7
相关论文
共 27 条
[1]   FALSE-POSITIVE RADIOIODINE WHOLE-BODY SCAN IN THYROID-CANCER PATIENTS DUE TO UNRELATED PATHOLOGY [J].
BAKHEET, SM ;
HAMMAMI, MM .
CLINICAL NUCLEAR MEDICINE, 1994, 19 (04) :325-329
[2]  
DADPARVAR S, 1993, CANCER, V71, P3767, DOI 10.1002/1097-0142(19930601)71:11<3767::AID-CNCR2820711146>3.0.CO
[3]  
2-W
[4]   Imaging in thyroid cancer [J].
Galloway, RJ ;
Smallridge, RC .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1996, 25 (01) :93-+
[5]  
HOEFNAGEL CA, 1986, J NUCL MED, V27, P1854
[6]   Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma [J].
Leger, FA ;
Izembart, M ;
Dagousset, F ;
Barritault, L ;
Baillet, G ;
Chevalier, A ;
Clerc, J .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (03) :242-246
[7]  
LINKS JM, 2000, WERNER INGBARS THYRO, P333
[8]  
LUBIN E, 1994, J NUCL MED, V35, P257
[9]   Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer [J].
Mandel, SJ ;
Shankar, LK ;
Benard, F ;
Yamamoto, A ;
Alavi, A .
CLINICAL NUCLEAR MEDICINE, 2001, 26 (01) :6-9
[10]  
MANDEL SJ, 1999, P 25 ANN M AM THYR A, P21